WO2010123571A2 - Animal feed compositions and feeding methods - Google Patents
Animal feed compositions and feeding methods Download PDFInfo
- Publication number
- WO2010123571A2 WO2010123571A2 PCT/US2010/001205 US2010001205W WO2010123571A2 WO 2010123571 A2 WO2010123571 A2 WO 2010123571A2 US 2010001205 W US2010001205 W US 2010001205W WO 2010123571 A2 WO2010123571 A2 WO 2010123571A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- feeding
- animal
- range
- concentration
- rumen
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 151
- 238000000034 method Methods 0.000 title claims abstract description 96
- 239000000203 mixture Substances 0.000 title claims abstract description 92
- 150000001875 compounds Chemical class 0.000 claims abstract description 81
- 230000001965 increasing effect Effects 0.000 claims abstract description 23
- 239000002253 acid Substances 0.000 claims description 125
- 210000004767 rumen Anatomy 0.000 claims description 104
- 150000007513 acids Chemical class 0.000 claims description 74
- 241000282849 Ruminantia Species 0.000 claims description 58
- 239000012530 fluid Substances 0.000 claims description 46
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 44
- 239000006047 digesta Substances 0.000 claims description 38
- 230000000968 intestinal effect Effects 0.000 claims description 38
- 150000003839 salts Chemical class 0.000 claims description 35
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 31
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 31
- 230000000977 initiatory effect Effects 0.000 claims description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 26
- 238000004519 manufacturing process Methods 0.000 claims description 23
- 229910021529 ammonia Inorganic materials 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 20
- 230000000236 ionophoric effect Effects 0.000 claims description 20
- 239000002555 ionophore Substances 0.000 claims description 19
- -1 feed ration Substances 0.000 claims description 17
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 16
- 229930195729 fatty acid Natural products 0.000 claims description 16
- 239000000194 fatty acid Substances 0.000 claims description 16
- 150000004665 fatty acids Chemical class 0.000 claims description 16
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 claims description 16
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims description 14
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 14
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 14
- 229920000570 polyether Polymers 0.000 claims description 14
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 claims description 13
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 13
- 229940070710 valerate Drugs 0.000 claims description 13
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims description 13
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 claims description 12
- 230000000694 effects Effects 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 11
- LSDULPZJLTZEFD-UHFFFAOYSA-N lupulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O LSDULPZJLTZEFD-UHFFFAOYSA-N 0.000 claims description 11
- 238000009472 formulation Methods 0.000 claims description 9
- 239000012453 solvate Substances 0.000 claims description 9
- 208000010444 Acidosis Diseases 0.000 claims description 7
- RMFGNMMNUZWCRZ-UHFFFAOYSA-N Humulone Natural products CC(C)CC(=O)C1=C(O)C(O)(CC=C(C)C)C(O)=C(CC=C(C)C)C1=O RMFGNMMNUZWCRZ-UHFFFAOYSA-N 0.000 claims description 7
- 230000007950 acidosis Effects 0.000 claims description 7
- 208000026545 acidosis disease Diseases 0.000 claims description 7
- VMSLCPKYRPDHLN-NRFANRHFSA-N humulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)[C@@](O)(CC=C(C)C)C1=O VMSLCPKYRPDHLN-NRFANRHFSA-N 0.000 claims description 7
- 239000003120 macrolide antibiotic agent Substances 0.000 claims description 7
- OLHLJBVALXTBSQ-UHFFFAOYSA-N Lupulone Natural products CC(C)CC(=O)C1C(=O)C(CC=C(C)C)C(=O)C(CC=C(C)C)(CC=C(C)C)C1=O OLHLJBVALXTBSQ-UHFFFAOYSA-N 0.000 claims description 6
- WPVSVIXDXMNGGN-UHFFFAOYSA-N beta-bitter acid Natural products CC(C)CC(=O)C1=C(O)C(CC=C(C)C)(CC=C(C)C)C(=O)C(CC=C(C)C)=C1O WPVSVIXDXMNGGN-UHFFFAOYSA-N 0.000 claims description 6
- 229930191564 Monensin Natural products 0.000 claims description 5
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 claims description 5
- 230000007423 decrease Effects 0.000 claims description 5
- 235000005911 diet Nutrition 0.000 claims description 5
- 230000037213 diet Effects 0.000 claims description 5
- 238000012423 maintenance Methods 0.000 claims description 5
- 229960005358 monensin Drugs 0.000 claims description 5
- LDXMPKMQIKGJFN-OKKPIIHCSA-N (6r)-3,5,6-trihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one Chemical compound CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)[C@](O)(CC=C(C)C)C1=O LDXMPKMQIKGJFN-OKKPIIHCSA-N 0.000 claims description 4
- VMSLCPKYRPDHLN-UHFFFAOYSA-N (R)-Humulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(O)(CC=C(C)C)C1=O VMSLCPKYRPDHLN-UHFFFAOYSA-N 0.000 claims description 4
- LDXMPKMQIKGJFN-SPLOXXLWSA-N Adhumulone Natural products O=C([C@@H](CC)C)C=1C(=O)[C@@](O)(C/C=C(\C)/C)C(O)=C(C/C=C(\C)/C)C=1O LDXMPKMQIKGJFN-SPLOXXLWSA-N 0.000 claims description 4
- QXPOWGXRDUFAQW-LJQANCHMSA-N Adlupulone Natural products O=C([C@@H](CC)C)C=1C(=O)C(C/C=C(\C)/C)(C/C=C(\C)/C)C(O)=C(C/C=C(\C)/C)C=1O QXPOWGXRDUFAQW-LJQANCHMSA-N 0.000 claims description 4
- DRSITEVYZGOOQG-UHFFFAOYSA-N Cohumulone Chemical compound CC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C(O)(CC=C(C)C)C1=O DRSITEVYZGOOQG-UHFFFAOYSA-N 0.000 claims description 4
- DRSITEVYZGOOQG-HXUWFJFHSA-N Cohumulone Natural products CC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)[C@](O)(CC=C(C)C)C1=O DRSITEVYZGOOQG-HXUWFJFHSA-N 0.000 claims description 4
- GEXOPZHAKQAGLU-UHFFFAOYSA-N Colupulone Natural products CC(C)C(=O)C1=C(O)C(CC=C(C)C)(CC=C(C)C)C(=O)C(CC=C(C)C)=C1O GEXOPZHAKQAGLU-UHFFFAOYSA-N 0.000 claims description 4
- QXPOWGXRDUFAQW-UHFFFAOYSA-N adlupulone Chemical compound CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O QXPOWGXRDUFAQW-UHFFFAOYSA-N 0.000 claims description 4
- UNCDMWKTFLUPHZ-UHFFFAOYSA-N colupulone Chemical compound CC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O UNCDMWKTFLUPHZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000003247 decreasing effect Effects 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 4
- QARXXMMQVDCYGZ-UHFFFAOYSA-N isohumulone Chemical compound CC(C)CC(=O)C1=C(O)C(O)(C(=O)CC=C(C)C)C(CC=C(C)C)C1=O QARXXMMQVDCYGZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 230000004060 metabolic process Effects 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- QHRQNLXYMFCGPB-UHFFFAOYSA-N 3,4-dihydroxy-2-(2-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one Chemical compound CCC(C)C(=O)C1=C(O)C(O)(C(=O)CC=C(C)C)C(CC=C(C)C)C1=O QHRQNLXYMFCGPB-UHFFFAOYSA-N 0.000 claims description 2
- SXCDPRLQEFPMBW-UHFFFAOYSA-N 4-methyl-1-[1,2,4-trihydroxy-3-(2-methylbutanoyl)-5-(3-methylbutyl)cyclopent-2-en-1-yl]pentan-1-one Chemical compound CCC(C)C(=O)C1=C(O)C(O)(C(CCC(C)C)C1O)C(=O)CCC(C)C SXCDPRLQEFPMBW-UHFFFAOYSA-N 0.000 claims description 2
- CNKVRZVLFXIJHB-UHFFFAOYSA-N CC(C)CCC(O)C1(O)C(CC=C(C)C)C(O)C(C(=O)C(C)C)=C1O Chemical compound CC(C)CCC(O)C1(O)C(CC=C(C)C)C(O)C(C(=O)C(C)C)=C1O CNKVRZVLFXIJHB-UHFFFAOYSA-N 0.000 claims description 2
- JENGQFYJSDYTDD-UHFFFAOYSA-N CC(C)CCC(O)C1(O)C(CC=C(C)C)C(O)C(C(=O)CC(C)C)=C1O Chemical compound CC(C)CCC(O)C1(O)C(CC=C(C)C)C(O)C(C(=O)CC(C)C)=C1O JENGQFYJSDYTDD-UHFFFAOYSA-N 0.000 claims description 2
- 229930193815 Isohumulone Natural products 0.000 claims description 2
- 239000006052 feed supplement Substances 0.000 claims description 2
- YDAFVJGIRJZGKB-UHFFFAOYSA-N hulupone Chemical compound CC(C)CC(=O)C1=C(O)C(=O)C(CC=C(C)C)(CC=C(C)C)C1=O YDAFVJGIRJZGKB-UHFFFAOYSA-N 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 230000004584 weight gain Effects 0.000 claims description 2
- 235000019786 weight gain Nutrition 0.000 claims description 2
- JIZQRWKUYFNSDM-UHFFFAOYSA-N 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one Chemical compound CC(C)CCC1C(=O)C(C(=O)CC(C)C)=C(O)C1(O)C(=O)CCC(C)C JIZQRWKUYFNSDM-UHFFFAOYSA-N 0.000 claims 1
- 241000218228 Humulus Species 0.000 description 72
- 229920000858 Cyclodextrin Polymers 0.000 description 33
- 235000002639 sodium chloride Nutrition 0.000 description 32
- YKGCBLWILMDSAV-GOSISDBHSA-N Isoxanthohumol Natural products O(C)c1c2C(=O)C[C@H](c3ccc(O)cc3)Oc2c(C/C=C(\C)/C)c(O)c1 YKGCBLWILMDSAV-GOSISDBHSA-N 0.000 description 27
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 26
- UVBDKJHYMQEAQV-UHFFFAOYSA-N xanthohumol Natural products OC1=C(CC=C(C)C)C(OC)=CC(OC)=C1C(=O)C=CC1=CC=C(O)C=C1 UVBDKJHYMQEAQV-UHFFFAOYSA-N 0.000 description 24
- FUSADYLVRMROPL-UHFFFAOYSA-N demethylxanthohumol Natural products CC(C)=CCC1=C(O)C=C(O)C(C(=O)C=CC=2C=CC(O)=CC=2)=C1O FUSADYLVRMROPL-UHFFFAOYSA-N 0.000 description 23
- 235000008209 xanthohumol Nutrition 0.000 description 23
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 20
- ORXQGKIUCDPEAJ-YRNVUSSQSA-N xanthohumol Chemical compound COC1=CC(O)=C(CC=C(C)C)C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 ORXQGKIUCDPEAJ-YRNVUSSQSA-N 0.000 description 20
- 238000011282 treatment Methods 0.000 description 18
- 239000003814 drug Substances 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- 239000000463 material Substances 0.000 description 16
- 229910052757 nitrogen Inorganic materials 0.000 description 15
- 229940124597 therapeutic agent Drugs 0.000 description 14
- 239000007788 liquid Substances 0.000 description 13
- 244000025221 Humulus lupulus Species 0.000 description 12
- 230000001079 digestive effect Effects 0.000 description 11
- 235000000346 sugar Nutrition 0.000 description 11
- 235000008694 Humulus lupulus Nutrition 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 9
- 229940088710 antibiotic agent Drugs 0.000 description 9
- 244000144972 livestock Species 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 241000283690 Bos taurus Species 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 229940097362 cyclodextrins Drugs 0.000 description 8
- 239000000651 prodrug Chemical class 0.000 description 8
- 229940002612 prodrug Drugs 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 238000005538 encapsulation Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 210000002249 digestive system Anatomy 0.000 description 6
- 239000002552 dosage form Substances 0.000 description 6
- 235000003599 food sweetener Nutrition 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 244000005706 microflora Species 0.000 description 6
- 238000012544 monitoring process Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 241000736262 Microbiota Species 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 240000008042 Zea mays Species 0.000 description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 5
- 235000005822 corn Nutrition 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 235000005985 organic acids Nutrition 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- QRDZSRWEULKVNW-UHFFFAOYSA-N 6-hydroxy-2-oxo-1h-quinoline-4-carboxylic acid Chemical compound C1=C(O)C=C2C(C(=O)O)=CC(=O)NC2=C1 QRDZSRWEULKVNW-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- RWECBKPOUYVUPL-UHFFFAOYSA-N Prehumulone Chemical compound CC(C)CCC(=O)C1=C(O)C(O)(CC=C(C)C)C(=O)C(CC=C(C)C)C1=O RWECBKPOUYVUPL-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- YKGCBLWILMDSAV-SFHVURJKSA-N isoxanthohumol Chemical compound C1([C@H]2OC=3C(CC=C(C)C)=C(O)C=C(C=3C(=O)C2)OC)=CC=C(O)C=C1 YKGCBLWILMDSAV-SFHVURJKSA-N 0.000 description 4
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 230000009918 complex formation Effects 0.000 description 3
- 239000011162 core material Substances 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 150000002148 esters Chemical group 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 150000004679 hydroxides Chemical class 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical group 0.000 description 3
- 235000013613 poultry product Nutrition 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 150000003733 xanthohumol Chemical class 0.000 description 3
- HOTYOZVURUOVTK-XNTDXEJSSA-N 2',4,4'-Trihydroxy-6'-methoxy-3',5'-diprenylchalcone Chemical compound COC1=C(CC=C(C)C)C(O)=C(CC=C(C)C)C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 HOTYOZVURUOVTK-XNTDXEJSSA-N 0.000 description 2
- ICKPYUKAWSXKMY-UHFFFAOYSA-N 3,5,6-trihydroxy-4,6-bis(3-methylbut-2-enyl)-2-propanoylcyclohexa-2,4-dien-1-one Chemical compound CCC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(O)(CC=C(C)C)C1=O ICKPYUKAWSXKMY-UHFFFAOYSA-N 0.000 description 2
- MTFYJZKXBWRLJA-UHFFFAOYSA-N 3,5-dihydroxy-4,6,6-tris(3-methylbut-2-enyl)-2-(4-methylpentanoyl)cyclohexa-2,4-dien-1-one Chemical compound CC(C)CCC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O MTFYJZKXBWRLJA-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- UVBDKJHYMQEAQV-XYOKQWHBSA-N 4'-O-methylxanthohumol Chemical compound OC1=C(CC=C(C)C)C(OC)=CC(OC)=C1C(=O)\C=C\C1=CC=C(O)C=C1 UVBDKJHYMQEAQV-XYOKQWHBSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 241000283726 Bison Species 0.000 description 2
- 241000282817 Bovidae Species 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 241000030939 Bubalus bubalis Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 108010025880 Cyclomaltodextrin glucanotransferase Proteins 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 240000004658 Medicago sativa Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000209056 Secale Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 150000001408 amides Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000009341 apiculture Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- RFBZVIDYTKNASZ-UHFFFAOYSA-N butanoic acid;2-methylpropanoic acid Chemical compound CCCC(O)=O.CC(C)C(O)=O RFBZVIDYTKNASZ-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000011111 cardboard Substances 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 150000001788 chalcone derivatives Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 238000005056 compaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- DUWPGRAKHMEPCM-IZZDOVSWSA-N isobavachalcone Chemical compound CC(C)=CCC1=C(O)C=CC(C(=O)\C=C\C=2C=CC(O)=CC=2)=C1O DUWPGRAKHMEPCM-IZZDOVSWSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013622 meat product Nutrition 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 238000005453 pelletization Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 description 1
- BLZMHRPUJFCGIJ-UXBLZVDNSA-N (e)-1-(3-hydroxy-5-methoxy-2,2-dimethyl-3,4-dihydrochromen-8-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one Chemical compound C1=2OC(C)(C)C(O)CC=2C(OC)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 BLZMHRPUJFCGIJ-UXBLZVDNSA-N 0.000 description 1
- LRSMBOSQWGHYCW-MDGZPELGSA-N (e)-1-[3-[(2e)-3,7-dimethylocta-2,6-dienyl]-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one Chemical compound CC(C)=CCC\C(C)=C\CC1=C(O)C=CC(C(=O)\C=C\C=2C=CC(O)=CC=2)=C1O LRSMBOSQWGHYCW-MDGZPELGSA-N 0.000 description 1
- XBFSDEKOTLYPJU-SXZUIPJJSA-N (e)-1-[3-[(2e)-3,7-dimethylocta-2,6-dienyl]-2-hydroxy-4-methoxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one Chemical compound OC1=C(C\C=C(/C)CCC=C(C)C)C(OC)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XBFSDEKOTLYPJU-SXZUIPJJSA-N 0.000 description 1
- OVBFMEVBMNZIBR-UHFFFAOYSA-N -2-Methylpentanoic acid Natural products CCCC(C)C(O)=O OVBFMEVBMNZIBR-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HOTYOZVURUOVTK-UHFFFAOYSA-N 2',4,4'-trihydroxy-6'-methoxy-3',5'-diprenylchalcone Natural products COC1=C(CC=C(C)C)C(O)=C(CC=C(C)C)C(O)=C1C(=O)C=CC1=CC=C(O)C=C1 HOTYOZVURUOVTK-UHFFFAOYSA-N 0.000 description 1
- HCSBTDBGTNZOAB-UHFFFAOYSA-N 2,3-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O HCSBTDBGTNZOAB-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- QGKBSGBYSPTPKJ-UZMKXNTCSA-N 2,6-di-o-methyl-β-cyclodextrin Chemical compound COC[C@H]([C@H]([C@@H]([C@H]1OC)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COC)[C@H]([C@@H]([C@H]3OC)O)O[C@H]3O[C@H](COC)[C@H]([C@@H]([C@H]3OC)O)O[C@H]3O[C@H](COC)[C@H]([C@@H]([C@H]3OC)O)O[C@H]3O[C@H](COC)[C@H]([C@@H]([C@H]3OC)O)O3)[C@H](O)[C@H]2OC)COC)O[C@@H]1O[C@H]1[C@H](O)[C@@H](OC)[C@@H]3O[C@@H]1COC QGKBSGBYSPTPKJ-UZMKXNTCSA-N 0.000 description 1
- DPZHKLJPVMYFCU-UHFFFAOYSA-N 2-(5-bromopyridin-2-yl)acetonitrile Chemical compound BrC1=CC=C(CC#N)N=C1 DPZHKLJPVMYFCU-UHFFFAOYSA-N 0.000 description 1
- OZDAOHVKBFBBMZ-UHFFFAOYSA-N 2-aminopentanedioic acid;hydrate Chemical compound O.OC(=O)C(N)CCC(O)=O OZDAOHVKBFBBMZ-UHFFFAOYSA-N 0.000 description 1
- KKXFYHZSOIALRM-UHFFFAOYSA-N 3,4-dihydroxy-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)-2-(2-methylpropanoyl)cyclopent-2-en-1-one Chemical compound CC(C)C(=O)C1=C(O)C(O)(C(=O)CC=C(C)C)C(CC=C(C)C)C1=O KKXFYHZSOIALRM-UHFFFAOYSA-N 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- XDKYBPGIBVMHHB-KPKJPENVSA-N 4-Hydroxyderricin Chemical compound OC1=C(CC=C(C)C)C(OC)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XDKYBPGIBVMHHB-KPKJPENVSA-N 0.000 description 1
- XDKYBPGIBVMHHB-UHFFFAOYSA-N 4-Hydroxyderricin Natural products OC1=C(CC=C(C)C)C(OC)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XDKYBPGIBVMHHB-UHFFFAOYSA-N 0.000 description 1
- HOOCUUOYPZNVKX-XYOKQWHBSA-N 4-O-methylxanthohumol Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)C1=C(O)C(CC=C(C)C)=C(O)C=C1OC HOOCUUOYPZNVKX-XYOKQWHBSA-N 0.000 description 1
- HOOCUUOYPZNVKX-UHFFFAOYSA-N 4-O-methylxanthohumol Natural products C1=CC(OC)=CC=C1C=CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C=C1OC HOOCUUOYPZNVKX-UHFFFAOYSA-N 0.000 description 1
- QISOBCMNUJQOJU-UHFFFAOYSA-N 4-bromo-1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1NN=CC=1Br QISOBCMNUJQOJU-UHFFFAOYSA-N 0.000 description 1
- PXACTUVBBMDKRW-UHFFFAOYSA-N 4-bromobenzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=C(Br)C=C1 PXACTUVBBMDKRW-UHFFFAOYSA-N 0.000 description 1
- OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- 235000002198 Annona diversifolia Nutrition 0.000 description 1
- 241000282815 Antilocapra americana Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283700 Boselaphus Species 0.000 description 1
- 241001124537 Bovinae Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 241000605900 Butyrivibrio fibrisolvens Species 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000283716 Connochaetes Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000168525 Croton tiglium Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 235000005853 Cyperus esculentus Nutrition 0.000 description 1
- 244000285774 Cyperus esculentus Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282818 Giraffidae Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- 241000248340 Isotricha Species 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 241000202974 Methanobacterium Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241000192029 Ruminococcus albus Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 240000003705 Senecio vulgaris Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241001493546 Suina Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 241000283968 Syncerus caffer Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241001416177 Vicugna pacos Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000019752 Wheat Middilings Nutrition 0.000 description 1
- LRSMBOSQWGHYCW-OAEBONLZSA-N Xanthoangelol Natural products CC(C)=CCC\C(C)=C/CC1=C(O)C=CC(C(=O)\C=C\C=2C=CC(O)=CC=2)=C1O LRSMBOSQWGHYCW-OAEBONLZSA-N 0.000 description 1
- ALGFNVZQNNGHPA-UHFFFAOYSA-N Xanthogalenol Natural products OC1=C(CC=C(C)C)C(OC)=CC(O)=C1C(=O)C=CC1=CC=C(O)C=C1 ALGFNVZQNNGHPA-UHFFFAOYSA-N 0.000 description 1
- CVMUWVCGBFJJFI-RMKNXTFCSA-N Xanthohumol C Chemical compound COC1=CC=2OC(C)(C)C=CC=2C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 CVMUWVCGBFJJFI-RMKNXTFCSA-N 0.000 description 1
- ZZXDRXVIRVJQBT-UHFFFAOYSA-M Xylenesulfonate Chemical compound CC1=CC=CC(S([O-])(=O)=O)=C1C ZZXDRXVIRVJQBT-UHFFFAOYSA-M 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000009418 agronomic effect Effects 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004977 anhydrous lactose Drugs 0.000 description 1
- 239000010828 animal waste Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical group 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical group 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000004464 cereal grain Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- KVSASDOGYIBWTA-UHFFFAOYSA-N chloro benzoate Chemical compound ClOC(=O)C1=CC=CC=C1 KVSASDOGYIBWTA-UHFFFAOYSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 210000000079 cloven hoof Anatomy 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- UGNIYZZWAOLMLH-UHFFFAOYSA-N dehydrocycloxanthohumol Natural products COC1=CC2OC(C)(C)C=CC2C(=C1C(=O)C=Cc3ccc(O)cc3)O UGNIYZZWAOLMLH-UHFFFAOYSA-N 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000004924 electrostatic deposition Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical group C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 239000005431 greenhouse gas Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- IZYBEMGNIUSSAX-UHFFFAOYSA-N methyl benzenecarboperoxoate Chemical compound COOC(=O)C1=CC=CC=C1 IZYBEMGNIUSSAX-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000002088 nanocapsule Substances 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000021442 non-organic meat Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 235000013348 organic food Nutrition 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- DYUMLJSJISTVPV-UHFFFAOYSA-N phenyl propanoate Chemical compound CCC(=O)OC1=CC=CC=C1 DYUMLJSJISTVPV-UHFFFAOYSA-N 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 229950009215 phenylbutanoic acid Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 235000021135 plant-based food Nutrition 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- UORVCLMRJXCDCP-UHFFFAOYSA-M propynoate Chemical compound [O-]C(=O)C#C UORVCLMRJXCDCP-UHFFFAOYSA-M 0.000 description 1
- 229950008679 protamine sulfate Drugs 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229910052903 pyrophyllite Inorganic materials 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- TYFQFVWCELRYAO-UHFFFAOYSA-L suberate(2-) Chemical compound [O-]C(=O)CCCCCCC([O-])=O TYFQFVWCELRYAO-UHFFFAOYSA-L 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940097346 sulfobutylether-beta-cyclodextrin Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 125000005270 trialkylamine group Chemical group 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- XBFSDEKOTLYPJU-DMCBTGHKSA-N xanthoangelol F Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)c(C/C=C(\CC/C=C(\C)/C)/C)c(OC)cc1 XBFSDEKOTLYPJU-DMCBTGHKSA-N 0.000 description 1
- BLZMHRPUJFCGIJ-IBGZPJMESA-N xanthoangelol H Natural products COc1ccc(C(=O)C=Cc2ccc(O)cc2)c3OC(C)(C)[C@@H](O)Cc13 BLZMHRPUJFCGIJ-IBGZPJMESA-N 0.000 description 1
- LRSMBOSQWGHYCW-UHFFFAOYSA-N xanthoangerol Natural products CC(C)=CCCC(C)=CCC1=C(O)C=CC(C(=O)C=CC=2C=CC(O)=CC=2)=C1O LRSMBOSQWGHYCW-UHFFFAOYSA-N 0.000 description 1
- ALGFNVZQNNGHPA-YRNVUSSQSA-N xanthogalenol Chemical compound OC1=C(CC=C(C)C)C(OC)=CC(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 ALGFNVZQNNGHPA-YRNVUSSQSA-N 0.000 description 1
- CVMUWVCGBFJJFI-UHFFFAOYSA-N xanthohumol C Natural products COC1=CC=2OC(C)(C)C=CC=2C(O)=C1C(=O)C=CC1=CC=C(O)C=C1 CVMUWVCGBFJJFI-UHFFFAOYSA-N 0.000 description 1
- 229940071104 xylenesulfonate Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
Definitions
- This invention relates to animal feed compositions.
- the invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of increasing and optimizing feed efficiency in animals.
- Livestock such as cattle, chickens, and pigs
- Animals that graze and eat low quality feed may be subject to a diet contaminated with bacteria, protozoa, yeast, viruses and parasites. Animals rely on the integrity of their digestive tracts and ruminant animals in particular are dependent on the optimal function of their rumen microflora.
- the rumen microflora is a complex system composed of a variety of microorganisms, and often of interest is the composition of bacteria and protozoa.
- Gram-negative bacteria are often considered to be beneficial to food and energy uptake, while certain Gram-positive bacteria and protozoa can reduce food and energy uptake and can be disruptive to rumen function.
- Ionophores are a class of antibiotics commonly used in animal feed. Ionophores are molecules that transport ions across biological membranes. Ionophores can have several oxygen atoms spaced throughout the molecule. The positions of the oxygen atoms create a cavity that can entrap cations.
- Ionophores have polar and non- polar regions that enhance cation entrapment and interaction with bacteria cell membranes. Ionophores are effective against Gram-positive bacteria and protozoa but generally innocuous to Gram-negative bacteria. By controlling the microorganism population and make-up in an animals digestive tract by inhibiting (or killing) select microorganisms, an animal's feed efficiency, as well as health and well being, can be improved.
- the invention relates to hop acid compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions.
- the compounds and compositions comprising them are useful for increasing and optimizing feed efficiency in animals, including those mediated by or associated with digestive system microbiota in animals.
- the methods of using hop acids for increasing food and energy uptake from feed by livestock is described which includes delivering the hop acids for oral ingestion to the animals by mixing the acids with livestock feed.
- the invention is directed at replacing antibiotics (e.g., . ionophore antibiotics, macrolide antibiotics) in animal feed with hop acids.
- antibiotics e.g., . ionophore antibiotics, macrolide antibiotics
- the hop plant Humulus lupulus, produces organic acids known as alpha acids (humulone) and beta acids (lupulone). These hop acids include but are not limited to alpha acids and beta acids but also their isomerized forms, isomerized/reduced forms, hydrogenated forms, isomerized/hydrogenated forms, oxidized forms, as well as any salt forms.
- Beta acids include lupulone, colupulone, adlupulone, prelupulone as well as other analogs.
- Alpha acids include humulone, cohumulone, adhumulone, posthumulone, and prehumulone, as well as other analogs. They consist of a complex hexagonal molecule with several side chains, with ketone and alcohol groups.
- Alpha acids are known to isomerize when exposed to heat to form isoalpha acids.
- Isoalpha acids and its reduced and/or hydrogenated forms namely rho-isoalpha acids, tetrahydro-isoalpha acids and hexahydro-isoalpha acids are hop acids commonly used to flavor beer.
- the compounds of this invention, and compositions comprising them are useful for increasing and optimizing feed efficiency in animals by administration of the compounds or compositions comprising the compounds to the subject animals. It is determined that efficiency is improved by careful maintenance of pH levels in the digestive system of the animal (e.g., rumen in ruminants) in a prescribed range.
- the feed composition does not comprise an added nitrogen source component.
- the added nitrogen source component could be urea.
- a method for feeding animals comprising administering to an animal a composition having an effective amount of hop acid wherein the pH of digestive fluid in the animal from the time immediately post feeding to 24 hours post- feeding is maintained in a range from about 5 to 8 (e.g., pH 5-7; pH 5-6).
- a method for feeding animals comprising administering to an animal a composition having an effective amount of hop acid wherein the pH of a digestive fluid sample taken from the time immediately post feeding to 24 hours post- feeding is in a range from about 5 to 7 (e.g., pH 5-7; pH 5-6).
- the pH ranges from about 5 to 6.
- the pH ranges from about 5.2 to about 7.
- the hop acid is hop beta acid.
- the amount of hop acid administered to the animal is between 0.1-1000 mg/day. In certain embodiments, the amount of hop acid administered to the animal is between 1 -300 mg/day.
- the animal is a ruminant animal.
- the animal is a bovine, an equine, a ruminant, a mammal, a food production animal, or the like.
- Another aspect is a method for feeding animals comprising administering to an animal a composition having an effective amount of hop acid, wherein the concentration in digestive (e.g., rumen) fluid in the animal from the time immediately upon initiation of feeding to 24 hours post-feeding of the following is one or more of the following: acetate is maintained in a range from about 30 to 50 mM; propionate is maintained in a range from about 20 to 45 mM; butyrate is maintained in a range from about 6 to 13 mM; isobutyrate is maintained in a range from about 0.5 to 1.1 mM; valerate is maintained in a range from about 2 to 4 mM; isovalerate is maintained in a range from about 1.5 to 2.5 mM; acetate:propionate concentration ratio is maintained in a range from about 0.75:2.95; total volatile fatty acid (VFA) is maintained in a range from about 70 to 110 mM; ammonia is maintained in a range from about 2 to 8 mM;
- Another aspect is a method for feeding animals comprising administering to an animal a composition having an effective amount of hop acid, wherein the concentration in digestive (e.g., rumen) fluid in the animal from the time immediately upon initiation of feeding to 20 hours post-feeding of the following is one or more of the following: acetate is maintained in a range from about 30 to 50 mM; propionate is maintained in a range from about 20 to 45 mM; butyrate is maintained in a range from about 6 to 13 mM; isobutyrate is maintained in a range from about 0.5 to 1.1 mM; valerate is maintained in a range from about 2 to 4 mM; isovalerate is maintained in a range from about 1.5 to 2.5 mM; acetate:propionate concentration ratio is maintained in a range from about 1.25:2.00; total volatile fatty acid (VFA) is maintained in a range from about 70 to 1 10 mM; ammonia is maintained in a range from about 2 to 8 mM
- the invention provides a method wherein the feed composition does not comprise an added nitrogen source component. [19] In other embodiments, the invention provides a method wherein the feed comprises a nitrogen source component. In certain embodiments, the component is urea.
- the invention provides a method wherein the animal is monitored.
- an animal is monitored for rumen fluid concentration levels for one or more of: acetate; propionate; butyrate isobutyrate; valerate; isovalerate; acetate:propionate concentration total volatile fatty acid (VFA); ammonia; or lactate.
- the invention provides a method wherein an animal is monitored for emission levels of methane, hydrogen sulfide or ammonia. Such monitoring is pursuant to compliance with a regulatory agency standard.
- a method of using hop acids as a natural addition to feed for livestock including delivering the hop acids for oral ingestion by mixing the acids with livestock feed.
- the acids are mixed with the feed in an amount to regulate levels of animal digestive bacteria and bacteria by-products (e.g., hydrocarbon end products) in the livestock's digestive system.
- the composition and method described allows for the production of polyether ionophoric compound free livestock.
- the amount of hop acid administered to the animal is between 0.1-100 mg/day; 0.1-200 mg/day; 1-300 mg/day; 50-200 mg/day; 80-160 mg/day; 125-175 mg/day (inclusive).
- the amount of hop acid administered to the animal is any range between (inclusive) a lower limit of a number between 0.1 -900 mg/day and an upper limit of a number between 1-1000 mg/day.
- the invention relates to a method of increasing and optimizing feed efficiency in a subject in need thereof including administering to the subject an effective amount of a compound herein, or acceptable salt, solvate or hydrate thereof (or composition thereof).
- the feed efficiency can be modulated by any animal digestive system microbiota, including those specifically delineated herein.
- the animal digestive system microbiota can be those that degrade plant fiber or other feed materials (e.g., alfalfa, barley, corn, grass, oats, rye, soy, straw, wheat, etc.).
- the animal digestive system microbiota can be methanogens, those that live in syntropic realtions with other digestive bacteria and protozoa that produce hydrogen and carbon dioxide end products.
- compositions and methods herein provide numerous benefits including providing improved and increased animal feeding efficiency; reduction of additional nitrogen source materials in the feed; improved uptake/usage of nitrogen; reduced ammonia waste generation by the animals; reduced methane generation by the animals; reduction in waste/waste disposal costs in animal production; improved environmental compliance in raising the animals; and generally regarded as safe (GRAS) compliant feeds/feed methods.
- GRAS safe
- hop acid includes organic acids known as alpha acids (humulone) and beta acids (lupulone). These hop acids include but are not limited to alpha acids and beta acids but also their isomerized forms, isomerized/reduced forms, hydrogenated forms, isomerized/hydrogenated forms, oxidized forms, as well as any salt forms, including salt forms in aqueous solutions.
- Beta acids include lupulone, colupulone, adlupulone, prelupulone as well as other analogs.
- Alpha acids include humulone, cohumulone, adhumulone, posthumulone, and prehumulone, as well as other analogs.
- Hop acids and hop acid salts used in the invention include commercially available products including, but not limited to, ALPHAHOPTM, BETASTABTM,
- compositions include an aqueous alkaline solution of a potassium salt of the corresponding hop acid.
- the compositions are known to those of ordinary skill in the art.
- the terms "monensin” and “rumensin” here are used interchangeably and refer to a compound that belongs to a family of polyether ionophore antibiotics.
- the chemical name is 4-[2-[5-ethyl-5-[5-[6-hydroxy-6-(hydroxymethyl)-3,5-dimethyl- oxan-2-yl]- 3-methyl-oxolan-2-yl]oxolan-2-yl]- 9-hydroxy-2,8-dimethyl-l ,6-dioxasp iro[4.5]dec-7-yl]-3-methoxy-2-methyl-pentanoic acid.
- Ruminant animal refers to a mammal of the order Artiodactyla that digests plant-based food by initially softening it within the animal's first stomach, then regurgitating the semi-digested mass, now known as cud, and chewing it again. The process of rechewing the cud to further break down plant matter and stimulate digestion is called "ruminating". Ruminating mammals include but are not limited to cattle, goats, sheep, giraffes, bison, yaks, water buffalo, deer, camels, alpacas, llamas, wildebeest, antelope, pronghorn, and nilgai.
- rumen forms the larger part of the reticulorumen, which is the first chamber in the alimentary canal of ruminant animals. It serves as the primary site for microbial fermentation of ingested feed.
- rumen health refers to a balance of microflora or bacteria in the rumen that is used to extract nutrients from feed.
- Various animal feeds are high in starch and/or carbohydrates, causing a decrease in rumen health resulting from microorganism growth, (e.g., Lactobacillus growth) and subsequent increase in lactate/lactic acid production.
- Bovine herein refers to the biological subfamily Bovinae, and includes a diverse group of 10 genera of medium to large sized ungulates, including domestic cattle, the bison, African buffalo, the water buffalo, the yak, and the four- horned and spiral-horned antelopes. General characteristics include cloven hoofs and usually at least one of the sexes of a species having true homs.
- a salt of a compound of this invention is formed between an acid and a basic group of the compound, such as an amino functional group, or a base and an acidic group of the compound, such as a carboxyl functional group.
- the compound is an animal feed acceptable acid addition salt.
- the term "derivative” means a structurally related compound that can hydrolyze, oxidize, or otherwise react under biological conditions (in vitro or in vivo) to provide a compound of this invention. Derivatives may only become active upon such reaction under biological conditions, or they may have activity in their unreacted forms. Examples of derivatives contemplated in this invention include, but are not limited to, analogs of compounds disclosed herein that comprise biohydrolyzable moieties such as amides, esters, carbamates, carbonates, and phosphate analogues.
- biohydrolyzable moiety means a functional group (e.g., amide, ester, carbamate, carbonate, or phosphate analogue, that either: 1) does not destroy the biological activity of the compound and confers upon that compound advantageous properties in vivo, such as uptake, duration of action, or onset of action; or 2) is itself biologically inactive but is converted in vivo to a biologically active compound.
- a functional group e.g., amide, ester, carbamate, carbonate, or phosphate analogue
- a derivative salt is a compound formed between an acid and a basic group of the derivative, such as an amino functional group, or a base and an acidic group of the derivative, such as a carboxyl functional group.
- the derivative salt is a animal feed acceptable salt.
- an "animal feed acceptable salt” means any non-toxic salt that, upon administration to a recipient, is capable of providing, either directly or indirectly, a compound or a derivative of a compound of this invention.
- Acids commonly employed to form acceptable salts include inorganic acids such as hydrogen bisulfide, hydrochloric, hydrobromic, hydroiodic, sulfuric and phosphoric acid, as well as organic acids such as para-toluenesulfonic, salicylic, tartaric, bitartaric, ascorbic, maleic, besylic, fumaric, gluconic, glucuronic, formic, glutamic, methanesulfonic, ethanesulfonic, benzenesulfonic, lactic, oxalic, para- bromophenylsulfonic, carbonic, succinic, citric, benzoic and acetic acid, and related inorganic and organic acids.
- Such animal feed acceptable salts thus include sulfate, pyrosulfate, bisulfate, sulfite, bisulfite, phosphate, monohydrogenphosphate, dihydrogenphosphate, metaphosphate, pyrophosphate, chloride, bromide, iodide, acetate, propionate, decanoate, caprylate, acrylate, formate, isobutyrate, caprate, heptanoate, propiolate, oxalate, malonate, succinate, suberate, sebacate, fumarate, maleate, butyne-l ,4-dioate, hexyne-l,6-dioate, benzoate, chlorobenzoate, methylbenzoate, dinitrobenzoate, hydroxybenzoate, methoxybenzoate, phthalate, terephathalate, sulfonate, xylenesulfonate, phenylacetate, phenyl
- Preferred animal feed acceptable acid addition salts include those formed with mineral acids such as hydrochloric acid and hydrobromic acid, and especially those formed with organic acids such as maleic acid.
- Suitable bases for forming animal feed acceptable salts with acidic functional groups of prodrugs of this invention include, but are not limited to, hydroxides of alkali metals such as sodium, potassium, and lithium; hydroxides of alkaline earth metal such as calcium and magnesium; hydroxides of other metals, such as aluminum and zinc; metals such as iron, copper, or any metal that can form a monvalent or divalent cationic species; ammonia, and organic amines, such as unsubstituted or hydroxy-substituted mono-, di-, or trialkylamines; dicyclohexylamine; tributyl amine; pyridine; N-methyl,N-ethylamine; diethylamine; triethylamine; mono-, bis-, or tris-(2- hydroxy-lower alkyl
- hydrate means a compound which further includes a stoichiometric or non-stoichiometric amount of water bound by non-covalent intermolecular forces.
- solvate means a compound which further includes a stoichiometric or non-stoichiometric amount of solvent such as water, acetone, ethanol, methanol, dichloromethane, 2-propanol, or the like, bound by non-covalent intermolecular forces.
- polymorph means solid crystalline forms of a compound or complex thereof which may be characterized by physical means such as, for instance, X-ray powder diffraction patterns or infrared spectroscopy. Different polymorphs of the same compound can exhibit different physical, chemical and/or spectroscopic properties.
- Different physical properties include, but are not limited to stability (e.g., to heat, light or moisture), compressibility and density (important in formulation and product manufacturing), hygroscopicity, solubility, and dissolution rates (which can affect bioavailability). Differences in stability can result from changes in chemical reactivity (e.g., differential oxidation, such that a dosage form discolors more rapidly when comprised of one polymorph than when comprised of another polymorph) or mechanical characteristics (e.g., tablets crumble on storage as a kinetically favored polymorph converts to thermodynamically more stable polymorph) or both (e.g., tablets of one polymorph are more susceptible to breakdown at high humidity).
- Different physical properties of polymorphs can affect their processing. For example, one polymorph might be more likely to form solvates or might be more difficult to filter or wash free of impurities than another due to, for example, the shape or size distribution of particles of it.
- stable compounds refers to compounds which possess stability sufficient to allow manufacture and which maintain the integrity of the compound for a sufficient period of time to be useful for the purposes detailed herein (e.g., formulation into feed products, intermediates for use in production of feed compounds, isolatable or storable intermediate compounds).
- Stepoisomer refers to both enantiomers and diastereomers.
- the recitation of a listing of chemical groups in any definition of a variable herein includes definitions of that variable as any single group or combination of listed groups.
- the recitation of an embodiment for a variable herein includes that embodiment as any single embodiment or in combination with any other embodiments or portions thereof.
- the compounds of this invention may contain one or more asymmetric centers and thus occur as racemates and racemic mixtures, single enantiomers, individual diastereomers and diastereomeric mixtures. All such isomeric forms of these compounds are expressly included in the present invention.
- the compounds of this invention may also be represented in multiple tautomeric forms, in such instances, the invention expressly includes all tautomeric forms of the compounds described herein. All such isomeric forms of such compounds are expressly included in the present invention. All crystal forms of the compounds described herein are expressly included in the present invention.
- compositions comprising an effective amount of a compound herein (e.g., alpha hop acid or beta hop acid, or salts thereof), or an animal feed acceptable salt, solvate, hydrate, polymorph or prodrug, if applicable, of said compound; and an acceptable carrier.
- a composition of this invention is formulated for animal feed use ("a feed composition"), wherein the carrier is a animal feed acceptable carrier.
- the carrier(s) must be "acceptable” in the sense of being compatible with the other ingredients of the formulation and, in the case of a animal feed acceptable carrier, not deleterious to the recipient thereof in amounts typically used in medicaments.
- Animal feed acceptable carriers, adjuvants and vehicles that may be used in the animal feed compositions of this invention include, but are not limited to, ion exchangers, alumina, aluminum stearate, lecithin, serum proteins, such as human serum albumin, buffer substances such as phosphates, glycine, sorbic acid, potassium sorbate, partial glyceride mixtures of saturated vegetable fatty acids, water, salts or electrolytes, such as protamine sulfate, disodium hydrogen phosphate, potassium hydrogen phosphate, sodium chloride, zinc salts, colloidal silica, magnesium trisilicate, polyvinyl pyrrolidone, cellulose-based substances, polyethylene glycol, sodium carboxymethylcellulose, polyacrylates, waxes, polyethylene- polyoxypropylene-block polymers, polyethylene glycol, propylene glycol and wool fat.
- ion exchangers alumina, aluminum stearate, lecithin
- serum proteins such as human serum albumin
- compositions include molasses, honey, and other coating materials.
- Such preparative methods include the step of bringing into association with the molecule to be administered ingredients such as the carrier that constitutes one or more accessory ingredients.
- the compositions are prepared by uniformly and intimately bringing into association the active ingredients with liquid carriers, liposomes or finely divided solid carriers or both, and then if necessary shaping the product.
- compositions of the present invention suitable for oral administration may be presented as discrete units such as capsules, sachets or tablets each containing a predetermined amount of the active ingredient; as a powder or granules; as a solution or a suspension in an aqueous liquid or a non-aqueous liquid; or as an oil-in-water liquid emulsion or a water-in-oil liquid emulsion, or packed in liposomes and as a bolus, etc.
- a composition of the present invention further comprises a second animal feed agent.
- the second therapeutic agent includes any compound or feed agent known to have or that demonstrates advantageous properties when administered with the hop acid compounds herein.
- the second therapeutic agent is an agent useful in the treatment or prevention of a disease or condition selected in the subject, including for example therapeutic agents, nutritional agents, feed efficiency agents.
- the compound of the present invention is present in an effective amount.
- effective amount refers to an amount which, when administered in a proper dosing regimen, is sufficient to exhibit a feed efficiency effect.
- the invention provides a method for enhancing the desired performance of a ruminant animal through the oral administration of a rumen pH modulating amount of a hop acid; wherein the ruminant animal is administered an animal feed that is free from a polyether ionophore compound or macrolide antibiotic.
- the invention provides a method for improving survival of a group of ruminant animals through the oral administration of a rumen pH modulating amount of a hop acid; wherein the survival is relative to a group of ruminant animals that is fed an animal feed that is free of a rumen pH modulating amount of a hop acid.
- the invention also provides a method for improving rumen health and functionality of a group of ruminant animals through the oral administration of a rumen pH modulating amount of a hop acid; wherein the rumen health and functionality are relative to a group of ruminant animals that is fed an animal feed that is free of a rumen pH modulating amount of a hop acid.
- the invention provides a method for enhancing the desired performance of a ruminant animal that had been administered a polyether ionophore or macrolide antibiotic containing an animal feed, comprising the step of discontinuing administration of a polyether ionophore or macrolide antibiotic feed, and administering a hop acid containing animal feed.
- the oral administration of hop acids in a ruminant's diet includes a feed composition, feed supplement, feed ration, water ration, mineral lick, and/or bolus.
- the hop acid is derived from a hop or hop source, or is produced synthetically.
- the hop acid is a hop ⁇ -acid, or a salt thereof.
- the hop ⁇ -acid is lupulone, colupulone, adlupulone, hexahydro-lupulone, hexahydro-colupulone, hexahydro-adlupulone, or hulupone, or salts thereof.
- the hop acid is a hop ⁇ -acid, or a salt thereof.
- the hop ⁇ -acid is humulone, cohumulone, adhumulone, isohumulone, isocohumulone, isoadhumulone, dihydro-isohumulone, dihydro- isocohumulone, dihydro-isoadhumulone, tetrahydr ⁇ -isohumulone, tetrahydro- isocohumulone, tetrahydro-isoadhumulone, hexahydro-isohumulone, hexahydro- isocohumulone, or hexahydro-isoadhumulone, or salts thereof.
- the amount of hop acid administered to the ruminant animal is between 0.1-1000 mg/animal/day. In a further embodiment, the hop acid is administered in an effective amount, including but not limited to, as part of a formulation, compounded mixture, salt, hydrate, solvate, and/or polymorph.
- the desired performance of a ruminant animal is an enhanced feed efficiency. In a further embodiment, the enhanced feed efficiency results in enhanced weight gain or enhanced milk production. [67] In another embodiment, the desired performance of a ruminant animal is decreased methane production.
- the desired performance of a ruminant animal is increased rumen ammonia production. In other embodiments, the desired performance is enhanced by in increase in rumen ammonia production. In a further embodiment, the desired performance of a ruminant animal is enhanced by an increase in ammonia concentration, and the ammonia concentration of a rumen fluid or intestinal digesta sample at any time immediately upon initiation of feeding to 24 hours post-feeding is in the range from about 2 to 8 mM. [69] In still another embodiment, the pH of a rumen fluid or intestinal digesta sample from the time immediately upon initiation of feeding to 24 hours post-feeding is maintained in a range from about 5 to 8.
- the pH of rumen fluid or intestinal digesta sample from the time immediately upon initiation of feeding to 24 hours post-feeding is maintained in the preferable range from about 5.2 to 7.
- the desired effect is to increase the pH of the rumen fluid or intestinal digesta by about 1% to about 25%; in certain embodiments about 1% to about 10%; in certain embodiments about 1% to about 5% using the method of the invention, compared to the pH measured from the rumen fluid or intestinal digesta of a ruminant animal feed an animal feed comprising a polyether ionophore compound, e.g., monensin.
- the increase in pH ranges from about 1% to about 3%.
- the increase in pH ranges from about 2% to about 4%. In other embodiments, the increase in pH ranges from about 3% to about 5%. In other embodiments, the increase in pH ranges from about 5% to about 10%. In other embodiments, the increase in pH ranges from about 10% to about 15%. In other embodiments, the increase in pH ranges from about 15% to about 25%. [711 In certain embodiments, the desired performance of a ruminant animal is enhanced by an increase in total volatile fatty acid content in the rumen fluid or intestinal digesta. In other embodiments, the desired performance is an increase in total volatile fatty acid content in the rumen fluid or intestinal digesta. In a further embodiment, the total volatile fatty acid concentration in rumen fluid or intestinal digesta sample at any time immediately upon initiation of feeding to 24 hours post- feeding is in the range from about 70 to 1 10 mM.
- the desired performance of a ruminant animal is enhanced by an increase in acetate concentration in the rumen fluid or intestinal digesta.
- the desired performance is an increase in acetate concentration in the rumen fluid or intestinal digesta.
- the concentration of acetate in rumen fluid or intestinal digesta sample at any time immediately upon initiation of feeding to 24 hours post-feeding is in the range from about 30 to 50 mM.
- the desired performance of a ruminant animal is increased rumen propionate production. In other embodiments, the desired performance of a ruminant animal is enhanced by increased rumen propionate production. In a further embodiment, the concentration of propionate in rumen fluid or intestinal digesta sample at any time immediately upon initiation of feeding to 24 hours post-feeding is in the range from about 20 to 45 mM. [74] In certain embodiments, the desired performance of a ruminant animal is enhanced by an increase in acetate to propionate concentration. In other embodiments, the desired performance of a ruminant animal is an increase in acetate to propionate concentration. In a further embodiment, the acetate to propionate concentration ratio in rumen fluid or intestinal digesta sample at any time immediately upon initiation of feeding to 24 hours post-feeding is maintained in a range from about 0.75 to 2.95.
- the desired performance of a ruminant animal is enhanced by a decrease in butyrate concentration.
- the desired performance of a ruminant animal is a decrease in butyrate concentration.
- the concentration of butyrate in rumen fluid or intestinal digesta sample at any time immediately upon initiation of feeding to 24 hours post-feeding is in the range from about 6 to 13 mM.
- the desired performance of a ruminant animal is enhanced by an increase in isobutyrate concentration.
- the desired performance of a ruminant animal is an increase in isobutyrate concentration.
- the concentration of isobutyrate in rumen fluid or intestinal digesta sample at any time immediately upon initiation of feeding to 24 hours post- feeding is in the range from about 0.5 to 1.1 mM.
- the desired performance of a ruminant animal is enhanced by an increase in valerate concentration.
- the desired performance of a ruminant animal is an increase in valerate concentration.
- the concentration of valerate in rumen fluid or intestinal digesta sample at any time immediately upon initiation of feeding to 24 hours post-feeding is in the range from about 2 to 4 mM.
- the desired performance of a ruminant animal is enhanced by an increase in isovalerate concentration.
- the desired performance of a ruminant animal is an increase in isovalerate concentration.
- the isovalerate concentration in rumen fluid or intestinal digesta sample at any time immediately upon initiation of feeding to 24 hours post- feeding is in the range from about 1.5 to 2.5 mM.
- the desired performance of a ruminant animal is a maintenance of lactate concentration. In other embodiments, the desired performance is enhanced by a maintenance of lactate concentration. In still other embodiments, the lactate concentration in rumen fluid or intestinal digesta sample is maintained in a range to minimize effects of dysfunctional ruminal metabolism. In a further embodiment, the lactate concentration in rumen fluid or intestinal digesta sample is within a desired range to prevent acidosis, subclinical acidosis and/or bloat. In still another further embodiment, the lactate concentration in rumen fluid or intestinal digesta sample at any time immediately upon initiation of feeding to 24 hours post- feeding is in the range from about 0 to 2 mM.
- the lactate concentration is reduced in rumen fluid or intestinal digesta sample to a range to minimize effects of dysfunctional ruminal metabolism.
- the animal feed does not comprise a polyether ionophore compound or macrolide antibiotic.
- the polyether ionophore compound is monensin.
- the animal or group of animals does not suffer from acidosis.
- the pH of an animal rumen is higher than the pH of an animal rumen that is administered an animal feed treated with a polyether ionophore compound in the absence of hop acids.
- What is surprising and unexpected about the method of the invention is the maintenance of pH upon administration of an animal feed comprising a hop acid or salt thereof.
- the rumen pH of a ruminant animal that is fed a monensin treated animal feed decreases to the point of causing acidosis in the animal.
- the concentration in rumen fluid or intestinal digesta sample from the time immediately upon initiation of feeding to 24 hours post-feeding of the following is : acetate is maintained in a range from about 30 to 50 mM; propionate is maintained in a range from about 20 to 45 mM; butyrate is maintained in a range from about 6 to 13 mM; isobutyrate is maintained in a range from about 0.5 to 1.1 mM; valerate is maintained in a range from about 2 to 4 mM; isovalerate is maintained in a range from about 1.5 to 2.5 mM; acetate:propionate concentration ratio is maintained in a range from about 0.75:2.95; total volatile fatty acid (VFA) is maintained in a range from about 70 to 1 10 mM; ammonia is maintained in a range from about 2 to 8 mM; and lactate concentration is maintained in a range from about 0 to 2 mM.
- the feed composition does not comprise an
- the feed composition further comprises a nitrogen source component.
- the nitrogen source component is urea, distillers grains, or other suitable nitrogen source, known to those of ordinary skill in the art.
- improving survival of a group of ruminant animals includes improving the health of various animals, e.g., lowering mortality rates, decreasing the number of sick/unhealthy animals, etc.
- the invention provides a method of increasing and optimizing feed efficiency in a subject comprising the step of administering to said subject an effective amount of a compound or a composition of this invention. Such diseases are well known in the art and are also disclosed herein.
- the invention provides a method of increasing and optimizing feed efficiency in a subject comprising the step of administering to said subject an effective amount of animal feed made by combining any animal feed material (e.g., plant matter, grasses, grains, cereals, including those delineated herein) with hop acids delineated herein.
- animal feed material e.g., plant matter, grasses, grains, cereals, including those delineated herein
- Methods delineated herein include those wherein the subject is identified as in need of a particular stated treatment. Identifying a subject in need of such treatment can be in the judgment of an animal care professional and can be subjective (e.g. opinion) or objective (e.g. measurable by a test or diagnostic method). [91] Methods delineated herein include those wherein a subject (an animal, a sample animal from a group or herd) is monitored.
- the monitoring can be performed to track progress of the feeding method or can track other measurements, including for example, measurement of emissions from an animal (e.g., methane production, ammonia production, hydrogen sulfide, environmental emission) subject to standards established by a regulatory agency (e.g., appropriate federal, state or local agency whether environmental, agricultural, food or other agency with regulatory jurisdiction); pH, chemical compound(s) concentration or ratios (e.g., including those delineated herein), chemical, bacterial, microbial, protein, nucleic acid other physicochemical or functional characteristic, or other marker.
- the monitoring can involve taking of one or more samples periodically through the feeding process, or from the animal after the feeding and digestion process is commenced or completed.
- the above method of treatment comprises the further step of co-administering to an animal one or more second therapeutic agents.
- the choice of second therapeutic agent may be made from any second therapeutic agent known to be useful for indications herein.
- co-administered means that the second therapeutic agent may be administered together with a compound of this invention as part of a single dosage form (such as a composition of this invention comprising a compound of the invention and an second therapeutic agent as described above) or as separate, multiple dosage forms. Alternatively, the additional agent may be administered prior to, consecutively with, or following the administration of a compound of this invention. In such combination therapy treatment, both the compounds of this invention and the second therapeutic agent(s) are administered by conventional methods.
- composition of this invention comprising both a compound of the invention and a second therapeutic agent to a subject does not preclude the separate administration of that same therapeutic agent, any other second therapeutic agent or any compound of this invention to said subject at another time during a course of treatment.
- the invention provides the use of a compound herein (e.g., hop acids) alone or together with one or more of the above-described second therapeutic agents in the manufacture of a feed composition or feed medicament, either as a single composition or as separate dosage forms, for treatment or prevention in a subject of a disease, disorder, symptom, or for improving feeding efficiency or animal growth, or other use set forth herein.
- a compound herein for use in the treatment or prevention in a subject of a disease, disorder symptom, or for improving feeding efficiency or animal growth, or other use set forth herein.
- the methods herein include those further comprising monitoring subject response to the treatment administrations.
- monitoring may include periodic sampling of subject tissue, fluids, specimens, cells, proteins, chemical markers, genetic materials, etc. as markers or indicators of the treatment regimen.
- the subject is prescreened or identified as in need of such treatment by assessment for a relevant marker or indicator of suitability for such treatment.
- the feeding method is adjusted based on monitoring information collected as described herein to regulate or achieve metrics or marker levels herein.
- kits for use to treat a subject in need of an animal feed composition comprising those where improved feed efficiency is desired.
- kits comprise: a) an animal feed composition comprising a hop acid compound of herein or a salt thereof; or a prodrug, or a salt of a prodrug thereof; or a hydrate, solvate, or polymorph thereof, wherein said animal feed composition is in a container; and b) instructions describing a method of using the animal feed composition to improve feed efficiency (i.e., relative to feed efficiency achieved by administration of feed without the compositions of the invention delineated herein).
- the container may be any vessel or other sealed or sealable apparatus that can hold said animal feed composition.
- Examples include bottles, divided or multi- chambered holders or bottles, wherein each division or chamber comprises a single dose of said composition, a divided foil packet wherein each division comprises a single dose of said composition, or a dispenser that dispenses single doses of said composition.
- the container can be in any conventional shape or form as known in the art which is made of an animal feed acceptable material, for example a paper or cardboard box, a glass or plastic bottle or jar, a re-sealable bag (for example, to hold a "refill" of tablets for placement into a different container), or a container with individual doses for pressing out of the container.
- the container employed can depend on the exact dosage form involved, for example a conventional cardboard box would not generally be used to hold a liquid suspension.
- hop acids significantly enhance the carbon source build-up via propionate and increased energy uptake by the animal by reducing butyrate production.
- Gram-negative bacteria are generally considered beneficial since they contribute to the break-down of cellulose into compounds beneficial for animal growth and energy.
- Gram-positive bacteria and protozoa are generally not beneficial since their digestive byproducts are not beneficial to the animal.
- the Gram-positive organisms that need to be controlled include Ruminococcus albus, R. ⁇ avefaciens and Butyrivibrio fibrisolvens. Controlling these micro-organisms has the beneficial effect of decreasing fermentation thus allowing more energy nutrients to go to the animal. Controlling the bacterium Methanobacterium ruminatium reduces the conversion of H 2 to methane gas.
- Controlling the various species of Streptococci and Lactobacilli also reduce the undesirable use of H 2 and allows more to be used in the desirable formation of propionate.
- Propionate is largely responsible for animal growth. Isotricha and Entodini are two protozoa which commonly infect the rumen. Again they take away energy and nutrients from the farm animal. During the fermentation, "good” and “bad” bacteria were allowed to compete for starch and fiber within these two feeds. Fermentations with low levels of alpha acids, beta acid, isoalpha acids, rho-isoalpha acids, tetrahydro-isoalpha acids and hexahydro-isoalpha acids are tested as well as a control that contained no hop acids. After rumenal fermentation was completed, end products were assayed to determine the effects of these hop acids.
- hop acids and salts thereof used in the methods of the invention may be preserved or treated in order to minimize degradation and/or oxidation.
- Methods of preservation or treatment of hop acids include, but are not limited to, encapsulation, compaction, chilsonation, pelletization, or extrusion. Such techniques, including the ones described below, allow for administration of a stable hop acid or salt thereof.
- a hop derivative is provided in an encapsulated formulation (liquid or powder).
- a hop derivative in liquid or powder form is encapsulated in a coating that breaks down slowly. The coating provides for the long- term release of the hop derivative.
- capsule materials include, but are not limited to, porous particulates or substrates such as silica, perlite, talc, clay, pyrophyllite, diatomaceous earth, gelatin and gels, polymers (e.g., polyurea, polyurethane, polyamide, polyester, etc.), polymeric particles, or cellulose.
- porous particulates or substrates such as silica, perlite, talc, clay, pyrophyllite, diatomaceous earth, gelatin and gels, polymers (e.g., polyurea, polyurethane, polyamide, polyester, etc.), polymeric particles, or cellulose.
- hollow fibers, hollow tubes or tubing which release a hop derivative or other compound specified above through the walls include, for example, hollow fibers, hollow tubes or tubing which release a hop derivative or other compound specified above through the walls, capillary tubing which releases the compound out of an opening in the tubing, polymeric blocks of different shapes, e.g., strips, blocks, tablets, discs, which release the compound out of the polymer matrix, membrane systems which hold the compound within an impermeable container and release it through a measured permeable membrane, and combinations of the foregoing.
- dispensing compositions are polymer laminates, polyvinyl chloride pellets, and microcapillaries. Encapsulation methods suitable for use in apiculture are described, for example, by Rieth et al., Journal of Apiculture Research 25(2):78-84 (1986).
- Encapsulation processes are typically classified as chemical or mechanical.
- Examples of chemical processes for encapsulation include, but are not limited to, complex coacervation, polymer-polymer incompatibility, interfacial polymerization in liquid media, in situ polymerization, in-liquid drying, thermal and ionic gelation in liquid media, desolvation in liquid media, starch-based chemistry processes, trapping in cyclodextrins, and formation of liposomes.
- Examples of mechanical processes for encapsulation include, but are not limited to, spray drying, spray chilling, fluidized bed, electrostatic deposition, centrifugal extrusion, spinning disk or rotational suspension separation, annular-jet encapsulation, polymerization at liquid-gas or solid-gas interface, solvent evaporation, pressure extrusion or spraying into solvent extraction bath.
- Microcapsules are also suitable for the long-term release of hop acids.
- Microcapsules are small particles that contain a core material or active ingredient surrounded by a coating or shell.
- the size of the microcapsule typically varies from 1 to 1000 microns with capsules smaller than 1 micron classified as nanocapsules and capsules larger than 1000 microns as macrocapsules.
- Core payload usually varies from 0.1 to 98 weight percent.
- Microcapsules can have a variety of structures (continuous core/shell, multinuclear, or monolithic) and have irregular or geometric shapes.
- the hop derivative is provided in an oil-based delivery system.
- the oil-hop derivative mix is deposited on a solid substrate and the substrate containing the hop derivative subsequently contacts and kills the bacteria.
- Oil release substrates include vegetable and/or mineral oils.
- the substrate also contains a surface active agent that renders the composition readily dispersable in water; such agents include wetting agents, emulsifying agents, dispersing agents, and the like.
- Hop acids of the invention can also be provided as emulsions.
- Emulsion formulations can be found as water in oil (w/o) or oil in water (o/w). Droplet size can vary from the nanometer scale (colloidal dispersion) to several hundred microns. A variety of surfactants and thickeners are usually incorporated in the formulation to modify the size of the droplets, stabilize the emulsion, and modify the release.
- hop acids of the invention may also be formulated in a solid tablet and comprise (and preferably consist essentially of) an oil, a protein/carbohydrate material (preferably vegetable based), and an active ingredient. Methods for making such compositions are known in the art and are described, for example, in U.S. Patent Publication No.
- the invention provides a solid tablet and comprise (and preferably consist essentially of) an oil, a protein/carbohydrate material (preferably vegetable based), and a hop acid. Tablets typically contain about 4-40% (e.g., 5%, 10%, 20%, 30%, 40%) by weight of an oil (e.g., plant oil, such as corn, sunflower, peanut, olive, grape seed, rung, turnip, soybean, cotton seed, walnut, palm, castor, earth almond, hazelnut, avocado, sesame, croton tiglium, cacao, linseed, rape-seed, and canola oils and their hydrogenated derivatives; petroleum derived oils (e.g., paraffins and petroleum jelly), and other water immiscible hydrocarbons (e.g., paraffins).
- an oil e.g., plant oil, such as corn, sunflower, peanut, olive, grape seed, rung, turnip, soybean, cotton seed, walnut, palm, castor, earth almond, hazelnut, avocado,
- the tablets further contain from about 5-40% (e.g., 5%, 10%, 20%, 30%, 40%) by weight of a vegetable-based protein/carbohydrate material.
- the material contains both a carbohydrate portion (e.g., derived from cereal grains such as wheat, rye, barley, oat, corn, rice, millet, sorghum, birdseed, buckwheat, alfalfa, and mielga, corn meal, soybean meal, grain flour, wheat middlings, wheat bran, corn gluten meal, algae meal, dried yeast, beans, rice) and a protein portion. While the relative fraction of each portion making up the material may vary, the material should include at least a portion of carbohydrate and protein.
- the tablets also contain between about 10-75% (10, 15, 20, 25, 50, 75%) by weight of a sweetener.
- the term "sweetener” generally refers to both natural and artificial sweeteners.
- the sweetener is a sugar such as glucose, fructose, sucrose, galactose, lactose, and reversed sugar.
- the sugar is preferably selected from the group consisting of granulated sugar (white sugar), brown sugar, confectioner's sugar, impalpable sugar, icing sugar, and combinations thereof. Alcohols such as glycerin and complex carbohydrates, such as starches may also be used as the "sweetener" ingredient.
- the sweetener helps to impart a granular structure to the tablets, especially when the sweetener is a sugar. As previously discussed, this granular structure permits the tablet to crumble over time upon the exertion of sufficient forces.
- various excipients and binders can be used in order to assist with delivery of the active ingredient or to provide the appropriate structure to the tablet.
- Preferred excipients and binders include anhydrous lactose, microcrystalline cellulose, corn starch, magnesium estearate, calcium estearate, zinc estearate, sodic carboxymethylcellulose, ethyl cellulose, hydroxypropyl methyl cellulose, and mixtures thereof.
- Tablets according to the present invention are manufactured by mixing all of the ingredients together and then compressing the mixture into a tablet of desired shape and size for a particular application.
- the tablet is discoid in shape with a diameter of between about 2-5 inches and a thickness of from about 0.5-2 inches.
- the pressing may be accomplished by a manual or automatic pressing device.
- the pressure exerted on the mixture should be sufficient so as to form the tablet into a self-sustaining body.
- the hop acids are prepared in a dusting composition.
- Dusting compositions are typically prepared by grinding sugar to a fine powder and mixing into the hops acids.
- the hop acids are prepared in a liquid spray composition that is formed by dispersing hops acids in any suitable liquid.
- the hops acids are dispersed in water.
- the spray composition also includes a surfactant that allows the spray to be dispersed efficiently without clogging the spraying apparatus.
- the composition can be used to spray the animal feed.
- the hop acids of the invention are delivered in the form of a vapor.
- compositions and methods featuring a water soluble xanthohumol/cyclodextrin complex having increased stability relative to xanthohumol alone or hop acid in the absence of a delivery complex.
- the invention generally features a composition comprising a xanthohumol (e.g., 3'-[3,3-dimethyl allyl]-2',4',4-trihydroxy-6'-methoxychalcone, a prenylated chalcone derived from hops, xanthoangelol, xanthoangelol F, 4- hydroxyderricin, 4-O-methylxanthohumol, isobavachalcone, xanthoangelol H, xanthogalenol, desmethoxyxanthohumol, 5'-prenylxanthohumol, tetrahydroxanthohumol, 2',4',6',4-terahydroxy-3'-C-geranylchalcone, dehydrocycloxanthohumol, 4-O-5'-C-diphenylxanthohumol, 4'-O-
- the invention provides a method of preparing a xanthohumol/cyclodextrin complex, comprising combining xanthohumol and cyclodextrin and adjusting the pH to 10-12, thereby providing for xanthohumol/cyclodextrin complex formation.
- the method further involves recovering the complex (e.g., by re-adjusting the pH to 6-9 to allow precipitation of the xanthohumol/cyclodextrin complex).
- the xanthohumol and cyclodextrin are present in water or a water-miscible solvent that is any one or more of methanol, ethanol, propanol, isopropanol, glycerine, ethylene, glycol, and polyethylene glycol (PEG).
- the water- miscible solvent is ethanol.
- cyclodextrin selectively forms a complex with xanthohumol.
- cyclodextrin fails to form a complex with isoxanthohumol or forms only a negligible amount (e.g., less than about 10%, 7%, 5%, 3%, 2%, 1%, 0.5% of the composition by weight) of a cycolextrin/isoxanthohumol complex.
- the invention provides a composition comprising a xanthohumol/cyclodextrin complex obtained by the method of a previous aspect or any method delineated herein.
- Xanthohumol (3'-[3,3-dimethyl allyl]-2',4',4- trihydroxy-6'-methoxychalcone) is a prenylated chalcone derived from hops (Humulus lupulus L.), specifically the female flowers of the hop plant, which are used in the brewing industry to add flavor and bitterness to beer.
- Xanthohumol isomerizes to form isoxanthohumol, particularly when compositions containing xanthohumol are heated or stored.
- xanthohumol may be complexed with cyclodextrin.
- Cyclodextrins are non- reducing, crystalline, water soluble, cyclic oligosaccharides that consist of glucose monomers arranged in a toroidal shape, which forms a tight conical cylinder having a hydrophilic exterior (due to the presence of hydroxyl radicals) and a hydrophobic interior cavity.
- the hydrophobic internal cavity provides for the formation of inclusion complexes with a variety of "guest" hydrophobic molecules (e.g. aromatics, alcohols, halides, fatty acids, esters).
- Naturally occurring cyclodextrins include ⁇ (6 sugar units), ⁇ (7 sugar units) and ⁇ (8 sugar units) cyclodextrins.
- Cyclodextrins can be modified by various procedures, such as substituting one or more hydrogen atoms in the primary and/or secondary hydroxyl groups. Chemically modified cyclodextrins exhibit substantially increased aqueous solubility while retaining the ability to form inclusion complexes. Cyclodextrin inclusion is a molecular phenomenon in which at least one guest molecule interacts with the cavity of a cyclodextrin molecule to form a stable association. Depending on the molecular weight of the guest, more than one guest molecule may fit into the cavity.
- Cyclodextrins form inclusion complexes with a broad range hydrophobic molecules. Complex formation may enhance the aqueous solubility of poorly soluble compounds and enhance the stability of agents susceptible to deterioration.
- Xanthohumol/cyclodextrin complexes can be prepared as described herein. Briefly, a hop acid, or salt thereof, comprising xanthohumol is mixed with a cyclodextrin and water or a water miscible solvent to form a mixture. The pH of the mixture is adjusted to 10-12 providing for complex formation between the cyclodextrin and the xanthohumol. The complex is recovered using any method known in the art, such as by collecting the mixture containing the complex or spray- drying the mixture to obtain a complex-containing powder. In one embodiment, insoluble materials are removed, and the mixture containing the complex is acidified to reach a pH value of 6-9, providing for complex precipitation.
- the mixture is then maintained at a suitable temperature (e.g., room temperature) for a sufficient period of time (e.g., 2 hr, 6 hr, or 12 hr) to provide for optimal precipitation.
- a suitable temperature e.g., room temperature
- a sufficient period of time e.g., 2 hr, 6 hr, or 12 hr
- the precipitated complex is then collected by any means known in the art, such as centrifugation or filtration. If desired, the precipate is washed with suitable solvents and dried.
- spent hops are used as the substance containing a xanthohumol compound, they are dispersed in water together with a cyclodextrin compound to form a mixture.
- the water-insoluble materials present in the spent hops are removed by any means known in the art, such as filtration or centrifugation.
- This step may be carried out before or after the pH is adjusted to 10- 12.
- a xanthohumol compound and a cyclodextrin compound are used as the starting materials in the aforementioned method, they are dissolved together in water or a water miscible solvent to form a solution.
- the xanthohumol compound is dissolved in water or a water miscible solvent first and then mixed with an aqueous solution containing the cyclodextrin compound to form a solution.
- the solution is then adjusted to pH 10-12.
- Xanthohumol/cyclodextrin compounds are then precipitated as described above.
- cyclodextrin selectively forms a complex with xanthohumol, but fails to form a complex with isoxanthohumol or forms a reduced level of such complexes.
- a composition of the invention comprises less than about 10%, 7%, 5%, 3%, 1%, 0.5% cyclodextrin/isoxanthohumol complexes.
- a xanthohumol-containing composition is likely to be useful an antioxidant.
- Xanthohumol is a well-known antioxidant. See e.g., Stevens et al., Chem. Res. Toxicol., 16(10): 1277-1286 (2003).
- the present invention provides methods of preventing oxidation and/or degradation of a hop acid which comprise administering an effective amount of a pharmaceutical composition comprising a hop acid to a ruminant animal.
- Methods of delivering an active ingredient to an animal feed according to the present invention comprise spray drying, encapsulation, chilsonation, compaction, pelletizing, extruding, and other methods known to those of ordinary skill in the art.
- Example 1 Analysis of ruminal samples from cattle fed hop beta acids.
- Cattle were fed concentrate-based diets and were administered beta acids of hops (0, 10, 80, 160, 240, or 300 mg/day) or Rumensin (300 mg/day) to determine effects of the additives on ruminal microbiota. Rumen samples were periodically taken and pH, acetate, propionate, butyrate isobutyrate, valerate isovalerate, and total volatile fatty acid (VFA) concentrations were measured.
- VFA volatile fatty acid
- Dilutions of the 10% beta acids solution were prepared (with water and KOH additions) such that solutions were prepared that contained the proper amount of beta acids (per ml) to provide proper cattle dose in 30 ml total volume (e.g. a solution was prepared that had 10mg/30ml (pH of 10.5) and was used to treat the 1 Omg/steer/day group; another solution was prepared that had 80mg/30ml (pH 10.5) and was used to treat the 80mg/steer/day group). Each animal was treated with it appropriate 30 ml of solution, once per day.
- a subset of ruminal fluid samples representing each of the seven treatment groups (control, five levels of beta acids and Rumensin). The beta acid levels were 10, 80 and 160, 240 and 300 mg/animal daily. The rumen fluid sampling was performed at prescribed intervals following feeding. Rumen samples were analyzed using standard accepted methodologies, and concentrations of parameters of interest determined.
- Results Described in Tables I through XI are the averaged results from the 24 hour feeding period (i.e. average of analysis results for each parameter, complied from samples taken and analyzed over the course of the 24 hour feeding period) for: the control animals, the animals receiving beta acids treatments (average value at all five levels), and Rumensin treated animals.
- the Tables provide the maximum, minimum and average values observed.
- the beta acids ( ⁇ -acids) and Rumensin values are reported as a percentage of the control. Positive percentage values mean that the treatment (beta acids or Rumensin) exceeded the control by the specified amount (negative values less than control by specified amount.
- Table I displays the results for rumen pH value.
- Table II displays the results for rumen ammonia concentration.
- Table III displays the results for rumen acetate concentration.
- Table IV displays the results for rumen propionate concentration.
- Table V displays the results for rumen acetate:propionate ratio.
- Table VI displays the results for rumen butyrate concentration.
- Table VII displays the results for rumen isobutyrate concentration.
- Table VIII displays the results for rumen valerate concentration.
- Table IX displays the results for rumen isovalerate concentration.
- Table X displays the results for rumen total VFA concentration.
- Table XI displays the results for rumen lactate concentration.
- the slightly higher pH of the rumen in beta acid treated animals was significant as pH is a log scale and a small change in pH towards neutrality has a significant effect on the microbial population and promotion of rumen enzymatic action.
- the rumen pH findings were supported by the rumen ammonia concentration findings. In Table II it was observed that rumen ammonia was higher for the beta acids treated animals. The rumen ammonia may contribute to a "buffering effect" on the rumen, and it may have been this buffering effect that helped the beta acids treated animals achieve a higher rumen pH than the Rumensin treated animals.
- the beta acids treated animals exceeded the control animals for fatty acid concentrations.
- the beta acid treated animals had fatty acid profiles indicative of excellent rumen performance.
- Table XI contained the rumen lactate concentration data, and as would be expected from a treatment that would control lactic acid (Gram-positive) organisms, the beta acids treated animals had low lactate levels.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2011011051A MX2011011051A (en) | 2009-04-21 | 2010-04-21 | Animal feed compositions and feeding methods. |
CA2759380A CA2759380A1 (en) | 2009-04-21 | 2010-04-21 | Animal feed compositions and feeding methods |
US13/265,731 US8969419B2 (en) | 2009-04-21 | 2010-04-21 | Animal feed compositions and feeding methods |
BRPI1006254A BRPI1006254A2 (en) | 2009-04-21 | 2010-04-21 | method for improving the desired performance of a ruminant animal, method for improving the rumen health and functionality of a group of ruminant animals, method for improving the desired performance of a ruminant animal receiving a polyether ionophore antibiotic or macrolide food-containing antibiotic animal |
CN201080026320.4A CN102481000B (en) | 2009-04-21 | 2010-04-21 | Animal feed composition and feeding method |
JP2012507218A JP2012524541A (en) | 2009-04-21 | 2010-04-21 | Animal feed composition and feed supply method |
EP10767434.3A EP2429311A4 (en) | 2009-04-21 | 2010-04-21 | Animal feed compositions and feeding methods |
NZ595585A NZ595585A (en) | 2009-04-21 | 2010-04-21 | Animal feed compositions and feeding methods |
AU2010239691A AU2010239691B2 (en) | 2009-04-21 | 2010-04-21 | Animal feed compositions and feeding methods |
ZA2011/07047A ZA201107047B (en) | 2009-04-21 | 2011-09-27 | Animal feed compositions and feeding methods |
US14/637,166 US20150313852A1 (en) | 2009-04-21 | 2015-03-03 | Animal feed compositions and feeding methods |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21430109P | 2009-04-21 | 2009-04-21 | |
US61/214,301 | 2009-04-21 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/265,731 A-371-Of-International US8969419B2 (en) | 2009-04-21 | 2010-04-21 | Animal feed compositions and feeding methods |
US14/637,166 Division US20150313852A1 (en) | 2009-04-21 | 2015-03-03 | Animal feed compositions and feeding methods |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010123571A2 true WO2010123571A2 (en) | 2010-10-28 |
WO2010123571A9 WO2010123571A9 (en) | 2011-04-07 |
Family
ID=43011667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/001205 WO2010123571A2 (en) | 2009-04-21 | 2010-04-21 | Animal feed compositions and feeding methods |
Country Status (13)
Country | Link |
---|---|
US (2) | US8969419B2 (en) |
EP (1) | EP2429311A4 (en) |
JP (1) | JP2012524541A (en) |
KR (1) | KR20120003009A (en) |
CN (1) | CN102481000B (en) |
AU (1) | AU2010239691B2 (en) |
BR (1) | BRPI1006254A2 (en) |
CA (1) | CA2759380A1 (en) |
CL (1) | CL2011002623A1 (en) |
MX (1) | MX2011011051A (en) |
NZ (1) | NZ595585A (en) |
WO (1) | WO2010123571A2 (en) |
ZA (1) | ZA201107047B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013107608A1 (en) | 2012-01-19 | 2013-07-25 | Dsm Ip Assets B.V. | Beadlets comprising hop acid salts in a starch matrix |
WO2013107607A1 (en) | 2012-01-19 | 2013-07-25 | Dsm Ip Assets B.V. | Beadlets comprising hop acid salts in a protein matrix |
WO2014013068A1 (en) * | 2012-07-20 | 2014-01-23 | Dr. Eckel Gmbh | Combination for reducing methane emissions in ruminant feeding |
CN105481893A (en) * | 2015-12-09 | 2016-04-13 | 广州英赛特生物技术有限公司 | Hexahydro beta-acid monophosphate derivative, and applications thereof in preparing animal feed additives |
EP3098214A1 (en) * | 2014-02-19 | 2016-11-30 | Guangzhou Insighter Biotechnology Co., Ltd | Hexahydrocolupulone monoester, inner complex salt or monoester salt, and application thereof as animal feed additive |
US20210000139A1 (en) * | 2018-03-16 | 2021-01-07 | Ajinomoto Co., Inc. | Animal feed additive and animal feed |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6029390B2 (en) * | 2011-09-07 | 2016-11-24 | 日本食品化工株式会社 | Method for producing xanthohumol / cyclodextrin inclusion complex-containing composition and use thereof |
CN103739487B (en) * | 2013-12-30 | 2015-10-28 | 广州英赛特生物技术有限公司 | β-acid monoester salt and the application as animal feedstuff additive thereof |
CN104710307A (en) * | 2015-02-16 | 2015-06-17 | 广州英赛特生物技术有限公司 | Hexahydrocolupulone di-aliphatic ester and utilization thereof as animal feed additive |
WO2017078521A1 (en) * | 2015-11-03 | 2017-05-11 | Purac Biochem B.V. | Anti-microbial agent comprising xanthohumol and the use thereof in food products |
CN105360623A (en) * | 2015-12-09 | 2016-03-02 | 广州英赛特生物技术有限公司 | Application of hop acid-beta-cyclodextrin inclusion compound in preparation of animal feed additives |
BR112018071835A2 (en) * | 2016-04-25 | 2019-02-19 | Can Technologies, Inc. | method for preparing a feed mixture, method of packaging a micro-ingredient and soluble feed container |
KR101904622B1 (en) * | 2016-12-27 | 2018-11-13 | 민경갑 | The functionality feed additive and functionality feed manufacturing method |
KR101955775B1 (en) * | 2016-12-27 | 2019-03-07 | 민경갑 | Functional fermented food additive and functionality health food manufacturing method |
CN109329595A (en) * | 2018-10-29 | 2019-02-15 | 齐鲁工业大学 | A kind of application of hop product substitute antibiotics on feed addictive |
KR102113974B1 (en) * | 2018-11-12 | 2020-05-20 | 경기도 | Aquaponics exclusive feed and producing method thereof |
ES2966220T3 (en) * | 2019-05-23 | 2024-04-19 | Guangzhou Insighter Biotechnology Co Ltd | Feed composition comprising hexahydro-ß-acid component compounds and their application |
CN114468150B (en) * | 2022-01-26 | 2022-11-25 | 南京农业大学 | Application of gentisic acid in promoting growth and rumen development of young ruminants |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4109019A (en) * | 1975-11-18 | 1978-08-22 | William Percy Moore | Process for improved ruminant feed supplements |
JP2603977B2 (en) | 1987-12-26 | 1997-04-23 | 日清製粉株式会社 | Prevention and treatment of Pasteurella haemolytica infection in livestock |
CN1035993C (en) * | 1994-01-15 | 1997-10-01 | 沈阳佳源国际医疗科技有限公司 | Method for preparing tetrahydro-iso-humulone from hop extract |
CN1058699C (en) * | 1998-10-06 | 2000-11-22 | 新疆大学 | Preparation of tetrahydroisoalpha acid from hops extract |
US20040044087A1 (en) * | 1999-03-05 | 2004-03-04 | Maye John Paul | Use of hop acids in fuel ethanol production |
DE19927574A1 (en) * | 1999-06-17 | 2000-12-21 | Basf Ag | Increasing content of flavonoids and phenols in plants, useful for e.g. preventing cardiovascular disease, by reducing activity of flavanone-3-hydroxylase |
WO2001076614A1 (en) | 2000-04-10 | 2001-10-18 | Takara Bio Inc. | Remedies |
NZ536090A (en) | 2002-05-17 | 2007-06-29 | Steiner Inc S S | Improved application for hop acids as anti-microbial agents |
EP1542543B1 (en) * | 2002-09-23 | 2013-11-13 | John I. Haas, Inc. | Hop acids as a replacement for antibiotics in animal feed |
CN1761459A (en) * | 2003-01-17 | 2006-04-19 | 麒麟麦酒株式会社 | Blood pressure-lowering agent, vascular flexibility-improving agent and foods having these functions imparted thereto |
PL1722635T3 (en) * | 2004-02-23 | 2016-06-30 | Sss Acquisition Llc | Feeds containing hop acids and uses thereof as supplements in animal feeds |
US8071136B2 (en) * | 2006-04-21 | 2011-12-06 | Bioactives, Inc. | Water-soluble pharmaceutical compositions of hops resins |
CN101011102A (en) | 2006-10-12 | 2007-08-08 | 玉门拓璞科技开发有限责任公司 | Use of hop slag for preparing animal fodder |
CN101376625A (en) * | 2008-10-07 | 2009-03-04 | 浙江大学 | Method for separating alpha and beta acid from hop extract |
CN101690545B (en) * | 2009-09-07 | 2012-10-17 | 肇东市日成酶制剂有限公司 | Method for producing complex micro-ecological preparation with microbial agents and enzyme |
-
2010
- 2010-04-21 KR KR1020117027582A patent/KR20120003009A/en not_active Application Discontinuation
- 2010-04-21 CN CN201080026320.4A patent/CN102481000B/en not_active Expired - Fee Related
- 2010-04-21 US US13/265,731 patent/US8969419B2/en not_active Expired - Fee Related
- 2010-04-21 JP JP2012507218A patent/JP2012524541A/en active Pending
- 2010-04-21 BR BRPI1006254A patent/BRPI1006254A2/en not_active IP Right Cessation
- 2010-04-21 AU AU2010239691A patent/AU2010239691B2/en not_active Expired - Fee Related
- 2010-04-21 NZ NZ595585A patent/NZ595585A/en not_active IP Right Cessation
- 2010-04-21 EP EP10767434.3A patent/EP2429311A4/en not_active Withdrawn
- 2010-04-21 CA CA2759380A patent/CA2759380A1/en not_active Abandoned
- 2010-04-21 WO PCT/US2010/001205 patent/WO2010123571A2/en active Application Filing
- 2010-04-21 MX MX2011011051A patent/MX2011011051A/en active IP Right Grant
-
2011
- 2011-09-27 ZA ZA2011/07047A patent/ZA201107047B/en unknown
- 2011-10-20 CL CL2011002623A patent/CL2011002623A1/en unknown
-
2015
- 2015-03-03 US US14/637,166 patent/US20150313852A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of EP2429311A4 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013107608A1 (en) | 2012-01-19 | 2013-07-25 | Dsm Ip Assets B.V. | Beadlets comprising hop acid salts in a starch matrix |
WO2013107607A1 (en) | 2012-01-19 | 2013-07-25 | Dsm Ip Assets B.V. | Beadlets comprising hop acid salts in a protein matrix |
WO2014013068A1 (en) * | 2012-07-20 | 2014-01-23 | Dr. Eckel Gmbh | Combination for reducing methane emissions in ruminant feeding |
EP3098214A1 (en) * | 2014-02-19 | 2016-11-30 | Guangzhou Insighter Biotechnology Co., Ltd | Hexahydrocolupulone monoester, inner complex salt or monoester salt, and application thereof as animal feed additive |
EP3098214A4 (en) * | 2014-02-19 | 2017-01-04 | Guangzhou Insighter Biotechnology Co., Ltd | Hexahydrocolupulone monoester, inner complex salt or monoester salt, and application thereof as animal feed additive |
US9573879B2 (en) | 2014-02-19 | 2017-02-21 | Guangzhou Insighter Biotechnology Co., Ltd. | Monoesters, inner complex salts or monoester salts of hexahydro-beta-acid and application thereof as animal feed additives |
CN105481893A (en) * | 2015-12-09 | 2016-04-13 | 广州英赛特生物技术有限公司 | Hexahydro beta-acid monophosphate derivative, and applications thereof in preparing animal feed additives |
US20210000139A1 (en) * | 2018-03-16 | 2021-01-07 | Ajinomoto Co., Inc. | Animal feed additive and animal feed |
Also Published As
Publication number | Publication date |
---|---|
JP2012524541A (en) | 2012-10-18 |
US20150313852A1 (en) | 2015-11-05 |
NZ595585A (en) | 2013-11-29 |
CA2759380A1 (en) | 2010-10-28 |
CL2011002623A1 (en) | 2012-03-09 |
KR20120003009A (en) | 2012-01-09 |
CN102481000B (en) | 2015-07-29 |
WO2010123571A9 (en) | 2011-04-07 |
AU2010239691A1 (en) | 2011-10-27 |
CN102481000A (en) | 2012-05-30 |
AU2010239691B2 (en) | 2015-09-03 |
EP2429311A4 (en) | 2014-03-26 |
BRPI1006254A2 (en) | 2016-08-09 |
US20120115960A1 (en) | 2012-05-10 |
ZA201107047B (en) | 2012-12-27 |
MX2011011051A (en) | 2012-06-01 |
US8969419B2 (en) | 2015-03-03 |
EP2429311A2 (en) | 2012-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8969419B2 (en) | Animal feed compositions and feeding methods | |
CN102480997B (en) | Improved method for conditioning animal feed | |
CN101107224B (en) | Valnemulin salts with organic acids | |
JP5502754B2 (en) | Feed for prevention and / or treatment of diseases caused by Clostridium bacteria in livestock, and anti-Clostridial agent | |
JP5914591B2 (en) | Ruminant reproduction efficiency improver | |
EP1843667B2 (en) | Food additive for ruminants based on eugenol and cinnamaldehyde | |
EP3973789B1 (en) | FEED COMPOSITION COMPRISING HEXAHYDRO-ß-ACID COMPONENT COMPOUNDS AND APPLICATION THEREOF | |
WO2009019335A2 (en) | Heat-resistant composition for animals, comprising an enzymatic mixture | |
WO2010053085A1 (en) | Agent for preventing acidosis in ruminant animals | |
TW201521592A (en) | Functional feed | |
KR101473851B1 (en) | Pellet-Type Composition for Prevention of Coccidiosis Symptom of Cattle Using Monensin and Manufacturing Method Thereof | |
JPS5925769B2 (en) | Veterinary drug composition and its manufacturing method | |
RU2783761C1 (en) | FEED COMPOSITION CONTAINING HEXAHYDRO-β-ACID DERIVATIVES AND ITS APPLICATION | |
FR2909558A1 (en) | Granulated medicated premixture, useful to treat infectious diseases, comprises orally administrable active ingredient, prepared by mixing the ingredient with a support/primary and secondary granulated excipient, wetting and stabilizing | |
RU1410524C (en) | Method for dry lactic acid bacterial preparation production | |
NL2010685C2 (en) | Animal feed material and use of the feed material. | |
CN113069468A (en) | A monatomic preparation for treating intestinal tract diseases of animals and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080026320.4 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10767434 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012507218 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 595585 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2011/011051 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011002623 Country of ref document: CL Ref document number: 2759380 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2010239691 Country of ref document: AU Date of ref document: 20100421 Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2010767434 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010767434 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20117027582 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13265731 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: PI1006254 Country of ref document: BR |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: PI1006254 Country of ref document: BR Free format text: IDENTIFIQUE O SIGNATARIO DAS PETICOES 018110040680 DE 19/10/2011 E 018110042923 DE 04/11/2011 E COMPROVE QUE O MESMO TEM PODERES PARA ATUAR EM NOME DO DEPOSITANTE, UMA VEZ QUE BASEADO NO ARTIGO 216 DA LEI 9.279/1996 DE 14/05/1996 (LPI) OS ATOS PREVISTOS NESTA LEI SERAO PRATICADOS PELAS PARTES OU POR SEUS PROCURADORES, DEVIDAMENTE QUALIFICADOS. . |
|
ENP | Entry into the national phase |
Ref document number: PI1006254 Country of ref document: BR Kind code of ref document: A2 Effective date: 20111019 |